Edinburgh, United Kingdom

Jonathan James Loughrey

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: An Insight into the Innovative Mind of Jonathan James Loughrey

Introduction: Jonathan James Loughrey is a visionary inventor based in Edinburgh, GB, with a trailblazing mindset that has led to numerous groundbreaking patents in the field of pharmaceuticals and therapeutics.

Latest Patents: Among his extensive portfolio of 10 patents, Jonathan's latest inventions are truly revolutionary. One of them includes the creation of organic acid addition salts of S-pindolol, which have shown promising applications in treating conditions such as cachexia, sarcopenia, neuromuscular disorders, and muscle weakness. Additionally, his work on polymorphic compounds as scavengers for toxic aldehydes has opened up new possibilities for treating diseases where aldehyde toxicity plays a significant role.

Career Highlights: Having worked with leading companies like Inspirna, Inc. and Nimbus Lakshmi, Inc., Jonathan has honed his skills and expertise in the field of pharmaceutical research and development. His relentless dedication to innovation has paved the way for transformative solutions in the healthcare industry.

Collaborations: Throughout his career, Jonathan has collaborated with esteemed professionals such as Stephen Wald and Eduardo J Martinez. These partnerships have been instrumental in bringing his visionary ideas to life and pushing the boundaries of scientific exploration.

Conclusion: Jonathan James Loughrey's inventive spirit and commitment to advancing healthcare solutions have solidified his position as a trailblazer in the field of pharmaceutical inventions. His patents stand as a testament to his ingenuity and dedication towards creating impactful change in the world of therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…